阿奇霉素联合布地奈德雾化吸入在支原体肺炎患儿治疗中的效果及对肺功能影响

Effect of Azithromycin Combined with Budesonide Nebulization in the Treatment of Children with Mycoplasma Pneumonia and Its Effect on Pulmonary Function

目的:探究阿奇霉素联合布地奈德雾化吸入在支原体肺炎患儿治疗中的效果及对肺功能影响。方法:选取2018年1月-2019年12月笔者所在医院收治的86例支原体肺炎患儿,采用随机数字表法分为两组,每组43例。对照组采用阿奇霉素治疗,观察组采用阿奇霉素联合布地奈德雾化吸入治疗,比较两组临床疗效、肺功能、咳嗽消失时间及住院时间。结果:观察组总有效率为95.35%,明显高于对照组的81.40%(P<0.05);观察组治疗后FEV1、VC、PEF水平均高于对照组(P<0.05);观察组咳嗽消失时间早于对照组,住院时间明显短于对照组(P<0.05)。结论:采用阿奇霉素联合布地奈德雾化吸入治疗支原体肺炎,能有效改善患儿肺功能,缩短住院时间,具有良好的临床效果。

Objective:To explore the effect of Azithromycin combined with Budesonide nebulization in the treatment of children with mycoplasma pneumonia and its effect on pulmonary function.Method:A total of 86 cases with mycoplasma pneumonia treated in our hospital from January 2018 to December 2019 were selected and divided into two groups by random number table method,43 cases in each group.The control group was treated with Azithromycin,and the observation group was treated with Azithromycin combined with Budesonide nebulization.The clinical efficacy,pulmonary function,time of disappearance of cough and hospitalization of the two groups were compared.Result:The total clinical effective rate in the observation group was 95.35%,which was significantly higher than 81.40%of the control group(P<0.05).After treatment,the FEV1,VC,PEF in the observation group were higher than those of the control group(P<0.05).The time of disappearance of cough was earlier,and hospitalization in the observation group was significantly shorter than those of the control group(P<0.05).Conclusion:Azithromycin combined with Budesonide nebulization for mycoplasma pneumonia can effectively improve the pulmonary function of children,shorten the time of hospitalization.It has a good clinical effect.